Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR202308758655839Not yet recruiting
Trial of midazolam, dexmedetomidine, gabapentin and Placebo-COD Research Private Ltd in Emergence agitation (EA) (4 arms), sponsored by sherif kamal hafez arafa. Primary endpoint: Incidence and severity of emergence agitation in PACU. Planned start Sep 2023; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR202308758655839.